MyFinsight
Home
Blog
About
Contact
Back
Income Statement
Vanda Pharmaceuticals Inc. (VNDA)
Vanda Pharmaceuticals Inc. (VNDA)
source: myfinsight.com
Download
Download image
Net loss
-$48,567K
(-64.67%↓ Y/Y)
Fanapt
$29,560K
Hetlioz
$15,947K
PONVORY
$6,211K
Loss before income
taxes
-$48,424K
(-29.59%↓ Y/Y)
Provision (benefit) for
income taxes
$143K
(101.82%↑ Y/Y)
Other income, net
$1,800K
(-50.82%↓ Y/Y)
net product sales
$51,718K
(3.35%↑ Y/Y)
Loss from operations
-$50,224K
(-22.41%↓ Y/Y)
Total revenues
$51,718K
(3.35%↑ Y/Y)
Total operating
expenses
$101,942K
(11.94%↑ Y/Y)
Selling, general and
administrative
$68,361K
(36.49%↑ Y/Y)
Research and development
$28,435K
(-20.38%↓ Y/Y)
Cost of goods sold
excluding amortization
$3,159K
(-10.28%↓ Y/Y)
Intangible asset
amortization
$1,987K
(13.41%↑ Y/Y)
Back